Artixio

Product Registration in Malaysia | Compliances Services

Product Registration Services in Malaysia for Life Sciences

Efficient Product Registration Services in Malaysia for All Life Sciences Industries. We assist with product registration and approval in Malaysia, liaising with NPRA and MDA to help you meet all regulatory requirements smoothly.

Product Registration Support for Life Sciences Companies in Malaysia

At Artixio, we simplify the product registration process in Malaysia, guiding you through each step to ensure your products meet the local regulatory requirements.
Whether you’re dealing with pharmaceuticals, medical devices, cosmetics, nutrition, biologics, or veterinary products, our team takes care of the complexities of getting your product approved by the relevant Malaysian authorities. With our expertise, your product is in safe hands from start to finish.

Product Registration Process in Malaysia

Our consultants support your product registration process in Malaysia, handling compliance, documentation, and local regulatory coordination. We manage the entire lifecycle of product registration in Malaysia

Product Classification
Documentation Preparation
Submission to NPRA
Regulatory Review
Approval & Market Release

Why Choose Artixio for Product Registration in Malaysia

FAQs

What is the role of the National Pharmaceutical Regulatory Agency (NPRA) in product registration?
NPRA is the regulatory body responsible for reviewing and approving all pharmaceutical, medical device, and other product registrations in Malaysia.
Product classification is based on the product’s intended use and risk category. Artixio assists in determining the right classification to ensure compliance.
Yes, foreign companies must appoint a local representative or authorized agent to handle the registration process and communications with NPRA.
Artixio provides full support in preparing the required documentation, navigating NPRA’s submission guidelines, and ensuring all regulatory requirements are met.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Registration Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Orphan Drug Designation in South Korea (MFDS)

Orphan Drug Designation in

Orphan Drug Designation (ODD) is regulated by Ministry of Food and Drug Safety (MFDS)...

November 4, 2025
Prioritizing Genes from Publicly Available GWAS Summary Stats Using AI

Prioritizing Genes from Publicly

Artixio has developed an artificial intelligence based solution generating a list of prioritized genes...

October 13, 2025
CDSCO Simplifies Subsequent Importer Process for Medical Devices & IVDs

CDSCO Simplifies Subsequent Importer

India’s regulatory authority, the Central Drugs Standard Control Organization (CDSCO), has published an important...

October 3, 2025